Unlocking the Potential of Target Product Profiles (TPPs) in Modern R&D: Exclusive Insights from a New Industry Survey

As the drug development landscape becomes increasingly competitive and complex, early-stage planning is crucial for success.

Yet, pharma and biotech companies take very different approaches – 71% of large pharma prioritize one key factor, while only 14% of biotech agree. 

Join IQVIA’s esteemed panel of experts for an exclusive first look at a new industry research conducted in collaboration with Citeline. This survey uncovers key trends in early-stage planning, including the factors prioritized most, the importance of early decisions, the role of target product profiles (TPPs), and the critical mistakes they make by not engaging a strategic partner to navigate the complexities of modern R&D.

Key takeaways include:

• Strategic Insights: Understand how early-stage planning can optimize drug development and the impact of early decisions on the lifecycle of an R&D program.
• TPP Trends: Discover the current trends in target product profiles, including traditional and innovative approaches, and their role in guiding research and development. 
• External Expertise: Learn about the benefits of incorporating external perspectives and expertise in strategic planning, with insights from successful collaborations.
• Overcoming Challenges: Gain strategies for addressing regulatory compliance, resource allocation, and risk management, and understand the importance of trial protocol design.
• Future Accelerators: Explore the potential of advanced technologies like AI to enhance biomarker-driven trials and optimize development scenarios.

Don't miss this opportunity to gain valuable insights and strategies to optimize your drug development process. Register now to secure your spot!

Meet the Speakers

Jin Chen

Therapeutic and Regulatory Strategy Vice President, Regulatory Affairs and Drug Development Solutions, IQVIA

Ian Fisher

Senior Director, Design Analytics, Regulatory Affairs and Drug Development Solutions, IQVIA

Manesh Bheda

Senior Director, Drug Development Team Lead, Regulatory Affairs and Drug Development Solutions, IQVIA